Edition:
United States

China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)

600062.SS on Shanghai Stock Exchange

17.55CNY
2:59am EDT
Change (% chg)

¥-0.17 (-0.96%)
Prev Close
¥17.72
Open
¥17.55
Day's High
¥17.75
Day's Low
¥17.40
Volume
2,800,238
Avg. Vol
5,311,398
52-wk High
¥34.98
52-wk Low
¥15.50

600062.SS

Chart for 600062.SS

About

CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in manufacture, processing and distribution of pharmaceuticals. The Company's products are classified into three categories: infusion solutions, including glucose injections, fructose injections and levofloxacin lactate and sodium... (more)

Overall

Beta: 0.73
Market Cap(Mil.): ¥12,852.11
Shares Outstanding(Mil.): 724.47
Dividend: 0.19
Yield (%): --

Financials

  600062.SS Industry Sector
P/E (TTM): 19.50 34.60 35.58
EPS (TTM): 0.91 -- --
ROI: 10.98 13.98 13.32
ROE: 11.17 15.11 14.59

BRIEF-China Resources Double-Crane Pharmaceutical receives drug clinical trial permission

May 24 China Resources Double-Crane Pharmaceutical Co., Ltd.:

May 24 2016

BRIEF-China Resources Double-Crane Pharma's 2015 net profit down 10.3 pct

March 10 China Resources Double-Crane Pharmaceutical Co Ltd

Mar 10 2016

BRIEF-China Resources Double-Crane Pharmaceutical unit gets GMP certificate

Jan 20 China Resources Double-Crane Pharmaceutical :

Jan 20 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Sadif Analytics Prime
$10.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.